Melanie Urbanek-Quaing

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Extracorporeal Membrane Oxygenation

Respiratory Syncytial Virus

Heat Shock Protein

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Thomas F Baumert, Melanie Urbanek-Quaing, Markus Cornberg
Immunomodulation and entry inhibition: selgantolimod's double punch against hepatitis B virus. Gut (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)
Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak, Melanie Urbanek-Quaing, Arnaud Carpentier, Antonia P Gunesch, Christina Grethe, Alina Matthaei, Jessica Rückert, Marie Galloux, Thibaut Larcher, Ronan Le Goffic, Fortune Hontonnou, Arnab K Chatterjee, Kristen A Johnson, Kaycie Morwood, Katharina Rox, Walid A M Elgaher, Jiabin Huang, Martin Wetzke, Gesine Hansen, Nicole Fischer, Jean-Francois Eléouët, Marie-Anne Rameix-Welti, Anna Katharina Herta Hirsch, Elisabeth Herold, Martin Empting, Chris Lauber, Thomas F Schulz, Thomas Krey, Sibylle Haid, Thomas Pietschmann
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor. Nature communications 15 (1) (2024)